Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eve T Rodler

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
American Journal of Nuclear Medicine and Molecular Imaging|November 8, 2012
(18)F-FDG PET in sarcoma treatment response imagingJanet F Eary, Douglas S Hawkins, Eve T Rodler, et al.
Sarcoma|February 19, 2011
Immune-based therapies for sarcomaSeth M Pollack, Elizabeth T Loggers, Eve T Rodler, et al.
Medical Oncology (Northwood, London, England)|March 5, 2013
Clinical benefit of trabectedin in uterine adenosarcomaBrett A Schroeder, Eve T Rodler, Elizabeth T Loggers, et al.
Rare Tumors|February 2, 2013
Systemic therapy in primary angiosarcoma of the spleenBruna Pellini Ferreira, Eve T Rodler, Elizabeth T Loggers, et al.
Medical Oncology (Northwood, London, England)|August 31, 2017
Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcomaRobin L Jones, Daniela Katz, Elizabeth T Loggers, et al.
Annals of Surgical Oncology|March 12, 2014
A contemporary large single-institution evaluation of resected retroperitoneal sarcomaPrashoban J Bremjit, Robin L Jones, Xiaoyu Chai, et al.
EJNMMI Research|June 27, 2012
Feasibility study of FDG PET as an indicator of early response to aromatase inhibitors and trastuzumab in a heterogeneous group of breast cancer patientsBrenda F Kurland, Vijayakrishna K Gadi, Jennifer M Specht, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2016
Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast CancerEve T Rodler, Brenda F Kurland, Melissa Griffin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2013
Phase I trial of preoperative chemoradiation plus sorafenib for high-risk extremity soft tissue sarcomas with dynamic contrast-enhanced MRI correlatesJanelle M Meyer, Kelly S Perlewitz, James B Hayden, et al.
Sarcoma|May 14, 2020
Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the LungKristin Baird, John Glod, Seth M Steinberg, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
American Journal of Nuclear Medicine and Molecular Imaging|November 8, 2012
(18)F-FDG PET in sarcoma treatment response imagingJanet F Eary, Douglas S Hawkins, Eve T Rodler, et al.
Sarcoma|February 19, 2011
Immune-based therapies for sarcomaSeth M Pollack, Elizabeth T Loggers, Eve T Rodler, et al.
Medical Oncology (Northwood, London, England)|March 5, 2013
Clinical benefit of trabectedin in uterine adenosarcomaBrett A Schroeder, Eve T Rodler, Elizabeth T Loggers, et al.
Rare Tumors|February 2, 2013
Systemic therapy in primary angiosarcoma of the spleenBruna Pellini Ferreira, Eve T Rodler, Elizabeth T Loggers, et al.
Medical Oncology (Northwood, London, England)|August 31, 2017
Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcomaRobin L Jones, Daniela Katz, Elizabeth T Loggers, et al.
Annals of Surgical Oncology|March 12, 2014
A contemporary large single-institution evaluation of resected retroperitoneal sarcomaPrashoban J Bremjit, Robin L Jones, Xiaoyu Chai, et al.
EJNMMI Research|June 27, 2012
Feasibility study of FDG PET as an indicator of early response to aromatase inhibitors and trastuzumab in a heterogeneous group of breast cancer patientsBrenda F Kurland, Vijayakrishna K Gadi, Jennifer M Specht, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2016
Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast CancerEve T Rodler, Brenda F Kurland, Melissa Griffin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2013
Phase I trial of preoperative chemoradiation plus sorafenib for high-risk extremity soft tissue sarcomas with dynamic contrast-enhanced MRI correlatesJanelle M Meyer, Kelly S Perlewitz, James B Hayden, et al.
Sarcoma|May 14, 2020
Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the LungKristin Baird, John Glod, Seth M Steinberg, et al.
Pageof 2